EN

Informator o strukturze Uczelni

Rozwiń
Strona główna jednostki
Publikacje (lista filadelfijska)
Profil
Prowadzone projekty badawcze
Start > Organizacja uczelni  > Podstawowe jednostki strukturalne  > Wydział Lekarski  > Katedra i Klinika Onkologii i Radioterapii

Katedra i Klinika Onkologii i Radioterapii

Wydział Lekarski

PUBLIKACJE (LISTA FILADELFIJSKA)

Publikacje w czasopismach z "listy filadelfijskiej" (z trzech ostatnich lat):

  1. Anti-cancer management of head and neck cancers and oral microbiome - what can we clinically obtain? - Makarewicz Jakub, KAŻMIERCZAK-SIEDLECKA KAROLINA, SOBOCKI BARTOSZ KAMIL, Dobrucki Iwona T., KALINOWSKI LESZEK, Stachowska Ewa - Front. Cell. Infect. Microbiol. - 2024 : vol. 14, art. ID 1329057, s. 1-8, bibliogr. [90] poz. streszcz. ang.
  2. Pembrolizumab-combination therapy for NSCLC-effectiveness and predictive factors in real-world practice - Knetki-Wróblewska Magdalena, DZIADZIUSZKO RAFAŁ, Jankowski Tomasz, Krawczyk Paweł, Bryl Maciej, Stencel Katarzyna, WRONA ANNA, BANDURA ARTUR, Smok-Kalwat Jolanta, Rok-Knapińska Jolanta, Szydziak-Zwierzyńska Kinga, Rogoziewicz Krzysztof, Czyżewicz Grzegorz, Wójtowicz Monika, Wojtukiewicz Marek, Kalinka Ewa, Wysocki Piotr J., Łobacz Mateusz, Milanowski Janusz, Pawlik Hubert, Kowalski Dariusz M., Krzakowski Maciej - Front. Oncol. - 2024 : vol. 14, art. ID 1341084, s. 1-10, bibliogr. 27 poz., streszcz. ang.
  3. Pregnancy after breast cancer in young BRCA carriers. An international hospital-based cohort study - Lambertini Matteo, Blondeaux Eva, Agostinetto Elisa, Hamy Anne-Sophie, Kim Hee Jeong, Meglio Antonio Di, Bernstein Molho Rinat, Hilbers Florentine, Pogoda Katarzyna, Carrasco Estela, Punie Kevin, Bajpai Jyoti, Ignatiadis Michail, Moore Halle C. F., Phillips Kelly-Anne, Toss Angela, Rousset-Jablonski Christine, Peccatori Fedro A., Renaud Tiphaine, Ferrari Alberta, Paluch-Shimon Shani, Fruscio Robert, Cui Wanda, Wong Stephanie M., Vernieri Claudio, Ruddy Kathryn J., Dieci Maria Vittoria, Matikas Alexios, Rozenblit Mariya, Villarreal-Garza Cynthia, De Marchis Laura, Del Mastro Lucia, Puglisi Fabio, Del Pilar Estevez-Diz Maria, Rodriguez-Wallberg Kenny A., Mrinakova Bela, Meister Sarah, Livraghi Luca, Clatot Florian, Yerushalmi Rinat, De Angelis Carmine, Sánchez-Bayona Rodrigo, Meattini Icro, CICHOWSKA-CWALIŃSKA NATALIA, Berlière Martine, Salama Mahmoud, De Giorgi Ugo, Sonnenblick Amir, Chiodi Camila, Lee Young-Jin, Maria Camille, Azim Hatem A., Boni Luca, Partridge Ann H. - JAMA - 2024 : vol. 331, nr 1, s. 49-59, bibliogr. 31 poz., streszcz. ang.
  4. Breast cancer highlights from 2023: Knowledge to guide practice and future research - Cardoso Maria Joao, Poortmans Philip, SENKUS-KONEFKA ELŻBIETA, Gentilini Oreste D., Houssami Nehmat - Breast - 2024 : vol. 74, art. ID 103674, s. 1-11, bibliogr. 39 poz., streszcz. ang.
  5. Neurotoxicity-sparing radiotherapy for brain metastases in breast cancer: a narrative review - BUCZEK DAGMARA, ZAUCHA RENATA, JASSEM JACEK - Front. Oncol. - 2024 : vol. 13, art. ID 1215426, s. 1-15, bibliogr. 125 poz., streszcz. ang.
  6. Extreme acute radiation-induced toxicity in a patient with polymorphous low-grade adenocarcinoma of the nasopharynx and rare variants in DNA repair genes - Nowicka Zuzanna, Kuna Kasper, Stawiski Konrad, Sołek Julia, Świderek Magdalena, Papis-Ubych Anna, Fijuth Jacek, Fendler Wojciech, TOMASIK BARTŁOMIEJ - Head Neck. - 2024 : vol. 46, nr 2, s. E10-E17, bibliogr. 39 poz., streszcz. ang.
  7. miR-122 and miR-21 are stable components of miRNA signatures of early lung cancer after validation in three independent cohorts - Żyła Joanna, DZIADZIUSZKO RAFAŁ, Marczyk Michał, SITKIEWICZ MAGDALENA, SZCZEPANOWSKA MAGDALENA, Bottoni Edoardo, Veronesi Giulia, RZYMAN WITOLD, Polańska Joanna, WIDŁAK PIOTR - J. Mol. Diagn. - 2024 : vol. 26, nr 1, s. 37-24, bibliogr. 34 poz., streszcz. ang.
  8. Cell-free DNA methylation profile potential in the diagnosis of lung squamous cell carcinoma - Du Chengli, Cai Ji, Tang Jie, Chen Yunhao, Díaz-Pena Roberto, Tomita Yusuke, JASSEM JACEK, Zhao Jiangang, Zheng Difang, Tu Zhengliang - J. Thorac. Dis. - 2024 : vol. 16, nr 1, s. 553-563, bibliogr. 28 poz., streszcz. ang.
  9. Quality indicators for evaluating cancer care in low-income and middle-income country settings: a multinational modified Delphi study - McLeod Megan, Torode Julie, Leung Kari, Bhoo-Pathy Nirmala, Booth Christopher, Chakowa Jade, Gralow Julie, Ilbawi Andre, JASSEM JACEK, Parkes Jeannette, Mallafré-Larrosa Merixtell, Mutebi Miriam, Pramesh CS, Sengar Manju, Tsunoda Audrey, Unger-Saldana Karla, Vanderpuye Verna, Yusuf Aasim, Sullivan Richard, Aggarwal Ajay - Lancet Oncol. - 2024 : vol. 25, nr 2, s. e63-e72, bibliogr. 59 poz., streszcz. ang.
  10. Repotrectinib in ROS1 fusion-positive non-small-cell lung cancer - Drilon A., Camidge D. R., Lin J. J., Kim S.-W., Solomon B. J., DZIADZIUSZKO RAFAŁ, Besse B., Goto K., de Langen A. J., Wolf J., Lee K. H., Popat S., Springfeld C., Nagasaka M., Felip E., Yang N., Velcheti V., Lu S., Kao S., Dooms C., Krebs M. G., Yap W., Beg M. S., Hu X., Moro-Sibilot D., Cheema P., Stopatschinskaja S., Mehta M., Trone D., Graber A., Sims G., Yuan Y., Cho B. C. - New Eng. J. Med. - 2024 : vol. 390, nr 2, s. 118-131, bibliogr. 20 poz., streszcz. ang.
  11. EONS advocacy toolkit: how to let your voice be heard as a cancer nurse - Protogiros D., van Klinken M.V., SUCHODOLSKA GRAŻYNA, Theologia T.A., Catania G., Knötgen G. - Ann. Oncol. - 2023 : vol. 34, suppl. 2, s. S1247-S1248
  12. Improved characterization of circulating tumor cells and cancer-associated fibroblasts in one-tube assay in breast cancer patients using imaging flow cytometry - MUCHLIŃSKA ANNA, WENTA ROBERT, Ścińska Wiktoria, MARKIEWICZ ALEKSANDRA, SUCHODOLSKA GRAŻYNA, SENKUS ELŻBIETA, ŻACZEK ANNA J., BEDNARZ-KNOLL NATALIA - Cancers - 2023 : vol. 15, nr 16, art. ID 4169, s. 1-15, bibliogr. 40 poz., streszcz. ang.
  13. Anti-HER2 drugs for the treatment of advanced HER2 positive breast cancer - STANOWICKA-GRADA MALWINA, SENKUS ELŻBIETA - Curr. Treat. Options Oncol. - 2023 : vol. 24, nr 11, s. 1633-1650, bibliogr. 56 poz., streszcz. ang.
  14. Patient and public involvement in research: reflections and experiences of doctoral cancer nurse researchers in Europe - Tanay Mary Anne, Diez de los Rios de la Serna Celia, Boland Vanessa, Da Silva Lopes André Manuel, Wingfield Karen, Chircop Daren, Dornan Mark, SUCHODOLSKA GRAŻYNA, Yildiz Aytaç Gülşah, Kurt Berna, Colomer-Lahiguera Sara - Eur. J. Oncol. Nurs. - 2023 : vol. 64, art. ID 102351, s. 1-8, bibliogr. [29] poz., streszcz. ang.
  15. Radiotherapy-induced dynamic changes in the lymphocyte-to-monocyte ratio in patients with laryngeal cancer indicate poor prognosis - CICHOWSKA-CWALIŃSKA NATALIA, BIEŃKOWSKI MICHAŁ, POPĘDA MARTA, Dróżka Magdalena, RUTKOWSKI JACEK, JASSEM JACEK, ZAUCHA RENATA - Front. Oncol. - 2023 : vol. 13, art. ID 1234953, s. 1-10, bibliogr. 60 poz., streszcz. ang.
  16. Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients? - KAŹMIERCZAK-SIEDLECKA KAROLINA, BULMAN NIKOLA, Ulasiński Paweł, SOBOCKI BARTOSZ KAMIL, POŁOM KAROL, Marano Luigi, KALINOWSKI LESZEK, Skonieczna-Żydecka Karolina - Gut Microbes - 2023 : vol. 15, nr 2, art. ID 2281017, s. 1-20, bibliogr. 148 poz., streszcz. ang.
  17. Are all societies ready for digital tools? Feasibility study on the use of mobile application in Polish early breast cancer patients treated with perioperative chemotherapy - SUCHODOLSKA GRAŻYNA, KOELMER ANNA, PUCHOWSKA MONIKA, SENKUS ELŻBIETA - Healthcare (Basel) - 2023 : vol. 11, nr 14, art. ID 2114, s. 1-16, bibliogr. 46 poz., streszcz. ang.
  18. Feasibility of online symptom monitoring to detect lung cancer relapse in Poland - PAWŁOWSKA EWA, Kaczmarczyk Anna, JASSEM JACEK - Ann. Oncol. - 2023 : vol. 34, suppl. 2, abs. 1236P
  19. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small-cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial - Remon J., Besse B., Ponce Aix S., Callejo A., Al-Rabi K., Bernabe R., Greillier L., Majem M., Reguart N., Monnet I., Cousin S., Garrido P., Robinet G., Garcia Campelo R., Madroszyk A., Mazières J., Curcio H., WASĄG BARTOSZ, Pretzenbacher Y., Fournier B., Dingemans A.-M.C., DZIADZIUSZKO RAFAŁ - Ann. Oncol. - 2023 : vol. 34, nr 5, s. 468-476, bibliogr. 27 poz., streszcz. ang.
  20. Randomized open-label controlled study of cancer vaccine OSE2101 versus chemotherapy in HLA-A2-positive patients with advanced non-small-cell lung cancer with resistance to immunotherapy: ATALANTE-1 - Besse B., Felip E., Garcia Campelo R., Cobo M., Mascaux C., Madroszyk A., Cappuzzo F., Hilgers W., Romano G., Denis F., Viteri S., Debieuvre D., Galetta D., Baldini E., Razaq M., Robinet G., Maio M., Delmonte A., Roch B., Masson P., Schuette W., Zer A., Remon J., Constantini D., Vasseur B., DZIADZIUSZKO RAFAŁ, Giaccone G. - Ann. Oncol. - 2023 : vol. 34, nr 10, s. 920-933, bibliogr. 37 poz., streszcz. ang.
  21. Is radiotherapy after primary chemotherapy (RAPCHEM) on the right path to de-escalation? / Koment. do: "De-escalation of radiotherapy after primary chemotherapy in cT1-2N1 breast cancer (RAPCHEM; BOOG 2010-03): 5-year follow-up results of a Dutch, prospective, registry study" / de Wild S. R., de Munck S., Simons J. M., Velroop J. i in. // Lancet Oncol., 2022, vol. 23, nr. 9, s. 1201-1210 - Socha Joanna, SENKUS ELŻBIETA - Ann. Transl. Med. - 2023 : vol. 11, nr 11, art. ID 149, s. 1-6, bibliogr. 23 poz.
  22. Abemaciclib + endocrine therapy (ET) for HR+, HER2-, node-positive, high-risk EBC: results from a pre-planned monarchE overall survival (OS) interim analysis (IA), including 4-year efficacy outcomes - Johnston S., Toi M., O'Shaughnessy J., Rastogi P., Campone M., Neven P., Huang C.S., Huober J., Garnica Jaliffe G., Cicin I., Tolaney S., Goetz M.P., Rugo H., SENKUS ELŻBIETA, Testa L., Del Mastro L., Shimizu C., Wei R., Shahir A., Munoz M., San Antonio B., Andre V., Harbeck N., Martín M. - Breast - 2023 : vol. 68, suppl. 1, s. S22-S23
  23. Overtreatment in early breast cancer - who is at risk? - SENKUS ELŻBIETA - Breast - 2023 : vol. 68, suppl. 1, s. S13
  24. Estrogen receptor-negative progesterone receptor-positive breast cancer is a molecularly distinct group characterized by the down-regulation of genes controlled by ESR1 and SUZ12 - KUNC MICHAŁ, POPĘDA MARTA, BIEŃKOWSKI MICHAŁ, Braun Marcin, Łacko Aleksandra, Radecka Barbara, Pikiel Joanna, Litwiniuk Maria, Pogoda Katarzyna, Niemira Magdalena, Szałkowska Anna, IŻYCKA-ŚWIESZEWSKA EWA, Cserni Gabor, BIERNAT WOJCIECH, SENKUS ELŻBIETA - Cancer Res. - 2023 : vol. 83, nr 5, suppl., abs. P2-23-06
  25. Abemaciclib plus endocrine therapy for HR+, HER2-, node-positive, high-risk early breast cancer: results from a pre-planned monarchE overall survival interim analysis, including 4-year efficacy outcomes - Johnston Stephen, Toi Masakazu, O'Shaughnessy Joyce, Rastogi Priya, Campone Mario, Neven Patrick, Huang Chiun Sheng, Huober Jens, Jaliffe Georgina Garnica, Cicin Irfan, Tolaney Sara, Goetz Matthew P., Rugo Hope, SENKUS ELŻBIETA, Testa Laura, Del Mastro Lucia, Shimizu Chikako, Wei Ran, Shahir Ashwin, Munoz Maria, San Antonio Belen, Andre Valerie, Harbeck Nadia, Martín Miguel - Cancer Res. - 2023 : vol. 83, nr 5, suppl., abs. GS1-09
  26. Molecular aspects of brain metastases in breast cancer - TOMASIK BARTŁOMIEJ, BIEŃKOWSKI MICHAŁ, Górska Zuzanna, Gutowska Klaudia, Kumięga Paulina, JASSEM JACEK, Duchnowska Renata - Cancer Treat. Rev. - 2023 : vol. 114, art. ID 102521, s. 1-13, bibliogr. 179 poz., streszcz. ang.
  27. Platelet-based liquid biopsies through the lens of machine learning - Cygert Sebastian, PASTUSZAK KRZYSZTOF, Górski Franciszek, Sieczczyński Michał, Juszczyk Piotr, Rutkowski Antoni, Lewalski Sebastian, Różański Robert, JOPEK MAKSYM ALBIN, JASSEM JACEK, Czyżewski Andrzej, Wurdinger Thomas, Best Myron G., ŻACZEK ANNA J., SUPERNAT ANNA - Cancers - 2023 : vol. 15, nr 8, art. ID 2336, s. 1-12, bibliogr. 46 poz., streszcz. ang.
  28. The effectiveness of cancer immune checkpoint inhibitor retreatment and rechallenge - a systematic review - PERDYAN ADRIAN, Sobocki Bartosz Kamil, Balihodzic Amar, Dąbrowska Anna, Kacperczyk Justyna, RUTKOWSKI JACEK - Cancers - 2023 : vol. 15, nr 13, art. ID 3490, s. 1-20, bibliogr. 66 poz., streszcz. ang.
  29. Cardiac arrhythmias in patients treated for lung cancer: a review - Hawryszko Maja, SŁAWIŃSKI GRZEGORZ, TOMASIK BARTŁOMIEJ, LEWICKA EWA - Cancers - 2023 : vol. 15, nr 24, art. ID 5723, s. 1-17, bibliogr. 101 poz., streszcz. ang.
  30. Treatment patterns, testing practices, and outcomes in patients with EGFR mutation-positive advanced non-small-cell lung cancer in Poland: a descriptive analysis of national, multicenter, real-world data from the REFLECT study - Pluzanski Adam, Bryl Maciej, Chmielewska Izabela, Czyzewicz Grzegorz, Luboch-Kowal Joanna, WRONA ANNA, Samborska Agnieszka, Krzakowski Maciej - Cancers - 2023 : vol. 15, nr 5, art. ID 1581, s. 1-12, bibliogr. 42 poz., streszcz. ang.
  31. Trimodality treatment of superior sulcus non-small cell lung cancer: an institutional series of 47 consecutive patients - RZYMAN WITOLD, Łazar-Poniatowska Małgorzata, DZIEDZIC ROBERT, MARJAŃSKI TOMASZ, Łapiński Mariusz, DZIADZIUSZKO RAFAŁ - Curr. Oncol. - 2023 : vol. 30, nr 5, s. 4551-4562, bibliogr. 26 poz., streszcz. ang.
  32. ESMO/ASCO recommendations for a global curriculum in medical oncology edition 2023 - Cufer Tanja, Kosty Michael P., Lordick Florian, Awada Ahmad, Bollin Kathryn, Gilbert Jill, Doonan Bently, Close Julia Lee, Seoane Joan, Furness Andrew, Mateo Joaquin, Gravitt Patti, Coleman Michel P., Korde Larissa A., Arber Nadir, Brewster Abeenaa, Edge Stephen, Siddon Alexa J., Tormey Christopher A., Peaper David R., Scarpa Aldo, Steen Julie, Behdad Amir, Marchiő Caterina, Stenzinger Albrecht, Zhou Yaolin, Kunz Wolfgang G., Ricke Jens, Fanti Stefano, Mankoff David A., Brierley James, Ohe Yuichiro, Litière Saskia, Raut Chandrajit P., Rutkowski Piotr, JASSEM JACEK, Liao Zhongxing, Herrmann Ken, Tempany Clare, Cass Amanda, Sessa Cristiana, de Azambuja Evandro, Higgins Michaela, Aggarwal Charu, Banerji Udai, Harrington Kevin, Hu-Lieskovan Siwen, Ghosh Monalisa, Ruhlmann Christina H., Roeland Eric J., Arends Jann, Cherny Nathan, Ferris Frank D., Baggstrom Maria Q., Dingemans Anne-Marie C., Patel Jyoti D., Popat Sanjay, Cho B.C. John, John Thomas, Girard Nicolas, Beri Nina, Cascinu Stefano, Smyth Elizabeth C., Zaanan Aziz, Azad Nilofer, Taieb Julien, Krishnamurthy Anuradha, Pernot Simon, Beri Nina, Decaens Thomas, Macarulla Teresa, Curigliano Giuseppe, Stringer-Reasor Erica Michelle, Bhangoo Munveer, Pickering Lisa, De Santis Maria, Spiess Philippe E., Fleming Mark T., Pezaro Carmel, Gietema Jourik A., Kollmannsberger Christian, Dudley Sara, Ledermann Jonathan A., Lorusso Domenica, Nero Camilla, Chuang Linus, Harter Philipp, Solheim Olesya, Perez Cesar A., Psyrri Amanda, Frezza Anna Maria, Thornton Katherine, Stacchiotti Silvia, Bauer Sebastian, Michielin Oliver, Navroze Amaria Rodabe, Wong Michael K., Plasmeijer Elsemieke, Becker Jürgen C., Locati Laura D., Wirth Lori J., Tiensuu Janson Eva, Rogers Sherise, Berruti Alfredo, Berber Eren, Batchelor tracy, Weller Michael, Esteller Manel, Hainsworth John D., Papayannidis Cristina, Xavier Marin, Sember Quinne, Patnaik Mrinal M., Platzbecker Uwe, Abramson Jeremy S., Gomes da Silva Maria, Hájek Roman, Mahindra Anuj, Daw Najat C., Saloustros Emmanouil, Wildiers Hans, Soto-Perez-de-Celis Enrique, Peccatori Fedro Alessandro, Hepner Adriana, Baldini Capucine, Extermann Martine, Berner Alison May, Maingi Shail, Remick Scot C., Halfdanarson Thorvardur R., Schapira Lidia, Travado Luzia, Giuliani Meredith, Ripamonti Carla Ida, Arun Banu, Balmana Judith, Blaes Anne, Zadravec Zaletel Lorna, Curigliano Giuseppe, Saltzman Joel N., Westphalen C. Benedikt, Perez-Gracia Jose Luis, Borras Josep Maria, Gospodarowicz Mary, Dickson Natalie, Lawler Mark, Rahman Jazieh Abdul, El-Saghir Nagi, Ginsburg Ophira, Trapani Dario, Eniu Alexandru, Chite Asirwa Frederick - ESMO Open - 2023 : vol. 8, nr 6, art. ID 101631, s. 1-67, bibliogr. [466] poz., streszcz. ang.
  33. OlympiAD extended follow-up for overall survival and safety: olaparib versus chemotherapy treatment of physician's choice in patients with a germline BRCA mutation and HER2-negative metastatic breast cancer - Robson Mark E., Im Seock-Ah, SENKUS ELŻBIETA, Xu Binghe, Domchek Susan M., Masuda Norikazu, Delaloge Suzette, Tung Nadine, Armstrong Anne, Dymond Mike, Fielding Anitra, Allen Allison, Conte Pierfranco - Eur. J. Cancer - 2023 : vol. 184, s. 39-47, bibliogr. 11 poz., streszcz. ang.
  34. Early biochemical and radiographic response after one cycle of 177 Lu Lu-PSMA I&T radioligand therapy in metastatic castration-resistant prostate cancer patients - CYTAWA WOJCIECH, Hendel Robin, TOMASIK BARTŁOMIEJ, Weinzierl Franz-Xaver, Bley Thorsten, JASSEM JACEK, Schirbel Andreas, Buck Andreas K., Bundschuh Ralph A., Hartrampf Philipp E., Werner Rudolf A., Lapa Constantin - Eur. J. Nucl. Med. Mol. Imaging - 2023 : vol. 50, nr 11, s. 3765-3776, bibliogr. 39 poz., streszcz. ang.
  35. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe - Grehn Melanie, Mandija Stefano, Miszczyk Marcin, Krug David, TOMASIK BARTŁOMIEJ, Stickney Kristine E., Alcantara Pino, Alongi Filippo, Anselmino Matteo, Salgado Aranda Ricardo, Balgobind Brian V., Boda-Heggemann Judit, Boldt Leif-Hendrick, Bottoni Nicola, Cvek Jakub, Elicin Olgun, De Ferrari Gaetano Maria, Hassink Rutger J., Hazelaar Colien, Hindricks Gerhard, Hurkmans Coen, Iotti Cinzia, Jadczyk Tomasz, Jiravski Otakar, Jumeau Raphaël, Kristiansen Steen Buus, Levis Mario, Algara López Manuel, Martí-Almor Julio, Mehrhof Felix, Sloth Møller Ditte, Molon Giulio, Ouss Alexandre, Peichl Petr, Plasek Jiri, Postema Pieter G., Quesada Aurelio, Reichlin Tobias, Rordorf Roberto, Rudic Boris, Saguner Ardan M., ter Bekke Rachel M. A., López Torrecilla José, Troost Esther G. C., Vitolo Viviana, Andratschke Nicolaus, Zeppenfeld Katja, Blamek Sławomir, Fast Martin, de Panfilis Ludovica, Blanck Oliver, Pruvot Etienne, Verhoeff Joost J. C. - Europace - 2023 : vol. 25, nr 4, s. 1284-1295, bibliogr. 58 poz., streszcz. ang.
  36. Pre-, intra- and post-neurosurgery language assessment in patient with astrocytoma, IDH1-mutant G3 - MARCINKOWSKA ANNA B., GRZYWIŃSKA MAŁGORZATA, Adamski Stanisław, SZUTOWICZ EWA, Winiarski Kacper, Czauderna Jan, WINKLEWSKI PAWEŁ J., Czarnota Katarzyna, Kloc Wojciech, SZUROWSKA EDYTA - Folia Neuropathol. - 2023 : vol. 61, nr 4, s. 468
  37. Zasady zapobiegania przeniesieniu nowotworu złośliwego od dawcy do biorcy przeszczepu. Oznaczanie markerów nowotworowych przy kwalifikacji dawców narządów. Stanowisko Grupy Roboczej Polskiego Towarzystwa Transplantacyjnego Wydanie trzecie uaktualnione - DĘBSKA-ŚLIZIEŃ ALICJA, Czerwiński Jarosław, Domański Leszek, Kosieradzki Maciej, SERKIES KRYSTYNA - Forum Nefrol. Edukacja - 2023 : vol. 3, nr 4, s. 155-191, bibliogr. 77 poz., streszcz. ang., pol.
  38. Radiation-induced circulating microRNAs linked to echocardiography parameters after radiotherapy - Chałubińska-Fendler Justyna, Nowicka Zuzanna, Dróżdż Izabela, Graczyk Łukasz, Piotrowski Grzegorz, TOMASIK BARTŁOMIEJ, Spych Michał, Fijuth Jacek, Papis-Ubych Anna, Kędzierawski Piotr, Kozono David, Fendler Wojciech - Front. Oncol. - 2023 : vol. 13, art. ID 1150979, s. 1-11, bibliogr. 58 poz., streszcz. ang.
  39. Plain language summary of the updated results from the CROWN study comparing lorlatinib with crizotinib in people with advanced non-small-cell lung cancer - Solomon Benjamin J., Bauer Todd M., Mok Tony S. K., Liu Geoffrey, Mazieres Julien, de Marinis Filippo, Goto Yasushi, Kim Dong-Wan, Wu Yi-Long, JASSEM JACEK, López López Froylán, Soo Ross A., Shaw Alice T., Polli Anna, Messina Rossella, Iadeluca Laura, Toffalorio Francesca, Felip Enriqueta - Future Oncol. - 2023 : vol. 19, nr 14, s. 961-973, streszcz. ang.
  40. Prospective analysis of the impact of adjuvant treatment with external beam radiation therapy and vaginal brachytherapy on health-related quality of life in patients with early-stage endometrioid endometrial carcinoma - Kluska Adam, TOMASIK BARTŁOMIEJ, Moszyńska-Zielińska Małgorzata, Zytko Leszek, Tracz Natalia, Spych Michał, Fijuth Jacek, Gottwald Leszek - Ginekol. Pol. - 2023 : vol. 94, nr 11, s. 867-873, bibliogr. 24 poz., streszcz. ang.
  41. Cardiac exposure in left-sided breast cancer patients undergoing deep inspiratory breath hold radiation therapy - Zhu Huijun, Sun Huiwen, Zhang Jiaming, Xie Yiting, JASSEM JACEK, Franco Pierfrancesco, Sun Weiliang, Liu Wenqi, Yue Haiying - Gland Surg. - 2023 : vol. 12, nr 5, s. 677-686, bibliogr. 30 poz., streszcz. ang.
  42. Exploratory efficacy analysis by smoking status in PD-L1 high patients in the phase III, non-small cell lung cancer (NSCLC) IMpower110 study - Paz-Ares L., Garcia-Campelo M. R., Isla Casado M. D., Carcereny E., Rodriguez Abreu D., Garcia Gonzalez J. J., Perez Parente D., Gonzalez Mancha N., Vilas E., Ruiz Gracia P., Greco A., Spigel D. R., de Marinis F., JASSEM JACEK - Immuno-oncol. Tech. - 2023 : vol. 20, suppl., s. 6, abs. 3P
  43. Olaparib efficacy in patients with germline BRCA-mutated, HER2-negative metastatic breast cancer: subgroup analyses from the phase III OlympiAD trial - SENKUS ELŻBIETA, Delaloge Suzette, Domchek Susan M., Conte Pierfranco, Im Seock-Ah, Xu Binghe, Armstrong Anne, Masuda Norikazu, Fielding Anitra, Robson Mark, Tung Nadine - Int. J. Cancer - 2023 : vol. 153, nr 4, s. 803-814, bibliogr. 30 poz., streszcz. ang.
  44. Vitamin D modulates the response of patient-derived metastatic melanoma cells to anticancer drugs - PIOTROWSKA ANNA, ZAUCHA RENATA, KRÓL OLIWIA, ŻMIJEWSKI MICHAŁ ALEKSANDER - Int. J. Mol. Sci. - 2023 : vol. 24, nr 9, art. ID 8037, s. 1-16, bibliogr. 80 poz., streszcz. ang.
  45. Real-world experience in treatment of patients with non-small-cell lung cancer with BRAF or cMET exon 14 skipping mutations - Janzic Urska, Shalata Walid, Szymczak Katarzyna, DZIADZIUSZKO RAFAŁ, Jakopovic Marko, Mountzios Giannis, Płużański Adam, Araujo Antonio, Charpidou Andriani, Agbarya Abed - Int. J. Mol. Sci. - 2023 : vol. 24, nr 16, art. ID 12840, s. 1-14, bibliogr. 64 poz., streszcz. ang.
  46. Target therapy in malignant pleural mesothelioma: hope or mirage? - Borea Federica, FRAŃCZAK MARIKA A., Garcia Maria, Perrino Matteo, Cordua Nadia, SMOLEŃSKI RYSZARD T., PETERS GODEFRIDUS J., DZIADZIUSZKO RAFAŁ, Santoro Armando, Zucali Paolo A., Giovannetti Elisa - Int. J. Mol. Sci. - 2023 : vol. 24, nr 11, art. ID 9165, s. 1-25, bibliogr. 159 poz., streszcz. ang.
  47. Impact of BMI in patients with early hormone receptor - positive breast cancer receiving endocrine therapy with or without palbociclib in the PALLAS trial - Pfeiler Georg, Hlauschek Dominik, Mayer Erica L., Deutschmann Christine, Kacerovsky-Strobl Stephanie, Martin Miguel, Meisel Jane Lowe, Zdenkowski Nicholas, Loibl Sibylle, Balic Marija, Park Haeseong, Prat Aleix, Isaacs Claudine, Bajetta Emilio, Balko Justin M., Bellet-Ezquerra Merixtell, Bliss Judith, Burstein Harold, Cardoso Fatima, Fohler Hannes, Foukakis Theodoros, Gelmon Karen A., Goetz Matthew, Haddad Tufia C., Iwata Hiroji, JASSEM JACEK, Lee Soo-Chin, Linderholm Barbro, Los Maartje, Mamounas Eleftherios P., Miller Kathy D., Morris Patrick G., Munzone Elisabetta, Gal-Yam Einav Nili, Ring Alistair, Shepherd Lois, Singer Christian, Thomssen Christoph, Tseng Ling-Ming, Valagusa Pinuccia, Winer Eric P., Wolff Antonio C., Zoppoli Gabriele, Machacek-Link Jana, Schurmans Celine, Huang Xin, Gauthier Eric, Fesl Christian, Dueck Amylou C., DeMichele Angela, Gnant Michael - J. Clin. Oncol. - 2023 : vol. 41, nr 33, s. 5118-5130, bibliogr. 30 poz., streszcz. ang.
  48. First-line nivolumab plus ipilimumab with chemotherapy versus chemotherapy alone for metastatic NSCLC in CheckMate 9LA: 3-year clinical update and outcomes in patients with brain metastases or select somatic mutations - Paz-Ares Luiz G., Ciuleanu Tudor-Eliade, Cobo Manuel, Bennouna Jaafar, Schenker Michael, Cheng Ying, Juan-Vidal Oscar, Mizutani Hideaki, Lingua Alejo, Reyes-Cosmelli Felipe, Reinmuth Niels, Menezes Juliana, JASSEM JACEK, Protsenko Svetlana, Richardet Eduardo, Felip Enriqueta, Feeney Kynan, Zurawski Bogdan, Alexandru Aurelia, de la Mora Jimenez Emmanuel, Dakhil Shaker, Lu Shun, Reck Martin, John Thomas, Hu Nan, Zhang Xiaoqing, Sylvester Judi, Eccles Laura J., Grootendorst Diederik J., Balli David, Neely Jaclyn, Carbone David P. - J. Thorac. Oncol. - 2023 : vol. 18, nr 2, s. 204-222, bibliogr. 56 poz., streszcz. ang.
  49. Efficacy of lorlatinib in treatment-naive patients with ALK-positive advanced NSCLC in relation to EML4::ALK variant type and ALK with or without TP53 mutations - Bearz Alessandra, Martini Jean-François, JASSEM JACEK, Kim Sang-We, Chang Gee-Chen, Shaw Alice T., Shepard Deborah, Dall'O' Elisa, Polli Anna, Thurm Holger, Zalcman Gerard, Garcia Campelo Maria Rosario, Penkov Konstantin, Hayashi Hidetoshi, Solomon Benjamin - J. Thorac. Oncol. - 2023 : vol. 18, nr 11, s. 1581-1593, bibliogr. 35 poz., streszcz. ang.
  50. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial - Johnston Stephen R. D., Toi Masakazu, O'Shaughnessy Joyce, Rastogi Priya, Campone Mario, Neven Patrick, Huang Chiun-Sheng, Huober Jens, Jaliffe Georgina Garnica, Cicin Irfan, Tolaney Sara M., Goetz Matthew P., Rugo Hope S., SENKUS ELŻBIETA, Testa Laura, Del Mastro Lucia, Shimizu Chikako, Wei Ran, Shahir Ashwin, Munoz Maria, San Antonio Belen, André Valérie, Harbeck Nadia, Martin Miguel - Lancet Oncol. - 2023 : vol. 24, nr 1, s. 77-90, bibliogr. 27 poz., streszcz. ang.
  51. Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups - Pasquier David, Bidaut Luc, Oprea-Lager Daniela Elena, deSouza Nandita M., Krug David, Collette Laurence, Kunz Wolfgang, Belkacemi Yazid, Bau Maria Grazia, Caramella Caroline, De Geus-Oei Lioe-Fee, De Caluwé Alex, Deroose Christophe, Gheysens Olivier, Herrmann Ken, Kindts Isabelle, Kontos Michalis, Kümmel Sherko, Linderholm Barbro, Lopci Egesta, Meattini Icro, Smeets Ann, Kaidar-Person Orit, Poortmans Philip, Tsoutsou Pelagia, Hajjaji Nawale, Russell Nicola, SENKUS ELŻBIETA, Talbot Jean-Noël, Umutlu Lale, Vandecaveye Vincent, Verhoeff Joost J. C., Menke-van der Houven van Oordt Willemien, Zacho Helle D., Cardoso Fatima, Fournier Laure, Van Duijnhoven Frederieke, Lecouvet Frédéric E. - Lancet Oncol. - 2023 : vol. 24, nr 8, s. e331-e343, bibliogr. 42 poz., streszcz. ang.
  52. European Groundshot-addressing Europe's cancer research challenges : a Lancet Oncology Commission - Lawler Mark, Davies Lynne, Oberst Simon, Oliver Kathy, Eggermont Alexander, Schmutz Anna, La Vecchia Carlo, Allemani Claudia, Lievens Yolande, Naredi Peter, Cufer Tanja, Aggarwal Ajay, Aapro Matti, Apostolidis Kathi, Baird Anne-Marie, Cardoso Fatima, Charalambous Andreas, Coleman Michel P, Costa Alberto, Crul Mirjam, Dégi Csaba L., Di Nicolantonio Federica, Erdem Sema, Geanta Marius, Geissler Jan, JASSEM JACEK, Jagielska Beata, Jonsson Bengt, Kelly Daniel, Kelm Olaf, Kolarova Teodora, Kutluk Tezer, Lewison Grant, Meunier Françoise, Pelouchova Jana, Philip Thierry, Price Richard, Rau Beate, Rubio Isabel T., Selby Peter, Južnič Sotlar Maja, Spurrier-Bernar Gilliosa, van Hoeve Jolanda C., Vrdoljak Eduard, Westerhuis Willien, Wojciechowska Urszula, Sullivan Richard - Lancet Oncol. - 2023 : vol. 24, nr 1, s. e11-e56, bibliogr. 240 poz., streszcz. ang.
  53. Efficacy and safety of first-line lorlatinib versus crizotinib in patients with advanced, ALK-positive non-small-cell lung cancer: updated analysis of data from the phase 3, randomised, open-label CROWN study - Solomon Benjamin J., Bauer Todd M., Mok Tony S. K., Geoffrey Liu, Mazieres Julien, de Marinis Filippo, Goto Yasushi, Kim Dong-Wan, Wu Yi-Long, JASSEM JACEK, Lopez Lopez Froylán, Soo Ross A., Shaw Alice T., Polli Anna, Messina Rossella, Iadeluca Laura, Toffalorio Francesca, Felip Enriqueta - Lancet Res. Med. - 2023 : vol. 11, nr 4, s. 354-366, bibliogr. 30 poz., streszcz. ang.
  54. Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide - Liu Stephen V., Mok Tony S. K., Nabet Barzin Y., Mansfield Aaron S., De Boer Richard, Losonczy György, Sugawara Shunichi, DZIADZIUSZKO RAFAŁ, Krzakowski Maciej, Smolin Alexey, Hochmair Maximilian J., Garassino Marina C., Gay Carl M., Heymach John V., Byers Lauren A., Lam Sivuonthanh, Cardona Andrés, Morris Stefanie, Adler Leah, Shames David S., Reck Martin - Lung Cancer - 2023 : vol. 186, art. ID 107418, s. 1-10, bibliogr. 42 poz., streszcz. ang.
  55. Comparison of three transcytotic pathways for distribution to brain metastases of breast cancer - Khan Imran, Gril Brundile, Paranjape Anurag N., Robinson Christina M., Difilippantonio Simone, BIERNAT WOJCIECH, BIEŃKOWSKI MICHAŁ, PĘKSA RAFAŁ, Duchnowska Renata, JASSEM JACEK, Brastianos Priscilla K., Metellus Philippe, Bialecki Emilie, Woodroofe Carolyn C., Wu Haitao, Swenson Rolf E., Steeg Patricia S. - Mol. Cancer Ther. - 2023 : vol. 22, nr 5, s. 646-658, bibliogr. 49 poz., streszcz. ang.
  56. Dynamics of the DYNLL1-MRE11 complex regulate DNA end resection and recruitment of Shieldin to DSBs - Swift Michelle L., Zhou Rui, Syed Aleem, Moreau Lisa A., TOMASIK BARTŁOMIEJ, Tainer John A., Konstantinopoulos Panagiotis A., D'Andrea Alan D., He Yizhou Joseph, Chowdhury Dipanjan - Nat. Struct. Mol. Biol. - 2023 : vol 30, nr 10, s. 1456-1467, bibliogr. 50 poz., streszcz. ang.
  57. Malignancies in adult kidney transplant candidates and recipients: current status - Serkies Krystyna, DĘBSKA-ŚLIZIEŃ ALICJA, KOWALCZYK ANNA, LIZAKOWSKI SŁAWOMIR, Małyszko Jolanta - Nephrol. Dial. Transplant. - 2023 : vol. 38, nr 7, s. 1591-1602, bibliogr. 128 poz., streszcz. ang.
  58. Single-agent divarasib (GDC-6036) in solid tumors with a KRAS G12C mutation - Sacher Adrian, LoRusso Patricia, Patel Manish R., Miller Wilson H., Garralda Elena, Forster Martin D., Santoro Armando, Falcon Alejandro, Kim Tae Won, Paz-Ares Luis, Bowyer Samantha, de Miguel Maria, Han Sae-Won, Krebs Matthew G., Lee Jong-Seok, Cheng Michael L., Arbour Kathryn, Massarelli Erminia, Choi Yoonha, Shi Zhen, Mandlekar Sandhya, Lin Mark T., Royer-Joo Stephanie, Chang Julie, Dharia Neekesh V., Schutzman Jennifer L., Desai Jayesh, i in., DZIADZIUSZKO RAFAŁ - New Eng. J. Med. - 2023 : vol. 389, nr 8, s. 710-721, bibliogr. 24 poz., streszcz. ang.
  59. Tarlatamab for patients with previously treated small-cell lung cancer - Ahn M.-J., Cho B.C., Felip E., Korantzis I., Ohashi K., Majem M., Juan-Vidal O., Handzhiev S., Izumi H., Lee J.-S., DZIADZIUSZKO RAFAŁ, Wolf J., Blackhall F., Reck M., Bustamante Alvarez J., Hummel H.-D., Dingemans A.-M.C., Sands J., Akamatsu H., Owonikoko T.K., Ramalingam S.S., Borghaei H., Johnson M.L., Huang S., Mukherjee S., Minocha M., Jiang T., Martinez P., Anderson E.S., Paz-Ares L. - New Eng. J. Med. - 2023 : vol. 389, nr 22, 2063-2075, bibliogr. 20 poz., streszcz. ang.
  60. Amivantamab plus chemotherapy in NSCLC with EGFR exon 20 insertions - Zhou C., Tang K.-J., Cho B.C., Liu B., Paz-Ares L., Cheng S., Kitazono S., Thiagarajan M., Goldman J.W., Sabari J.K., Sanborn R.E., Mansfield A.S., Hung J.-Y., Boyer M., Popat S., Mourão Dias J., Felip E., Majem M., Gumus M., Kim S., Ono A., Xie J., Bhattacharya A., Agrawal T., Shreeve S.M., Knoblauch R.E., Park K., Girard N., i in., DZIADZIUSZKO RAFAŁ - New Eng. J. Med. - 2023 : vol. 389, nr 22, 2039-2051, bibliogr. 34 poz., streszcz. ang.
  61. First-Line selpercatinib or chemotherapy and pembrolizumab in RET fusion - positive NSCLC - Zhou Caicun, Solomon Benjamin, Loong Herbert H., Park Keunchil, Pérol Maurice, Arriola Edurne, Novello Silvia, Han Baohui, Zhou Jianying, Ardizzoni Andrea, Mak Perez, Santini Fernando C., Elamin Yasir Y., Drilon Alexander, Wolf Jürgen, Payakachat Nalin, Uh Minji K., Rajakumar Deborah, Han Hongmei, Puri Tarun, Soldatenkowa Victoria, Lin Bence, Lin Boris K., Goto Koichi, i in., DZIADZIUSZKO RAFAŁ - New Eng. J. Med. - 2023 : vol. 389, nr 20, s. 1167-1179, bibliogr. 24 poz., streszcz. ang.
  62. Perspectives for cancer care and research in Central and Eastern Europe - Zielinski Christoph C., Cufer Tanja, Seruga Bostjan, JASSEM JACEK, Dediu Mircea, Thallinger Christiane - Oncol. Res. Treat. - 2023 : vol. 46, nr 3, s. 80-88, bibliogr. 55 poz., streszcz. ang.
  63. Characterization of long-term survivors in the TOPAZ-1 study of durvalumab or placebo plus gemcitabine and cisplatin in advanced biliary tract cancer - Finkelmeier F., Bouattour M., Valle J. V., Vogel A., Kim J. W., Kitano M., Chen J. S., Burris H., ZAUCHA RENATA, Qin S., Evesque L., Zhen D. B., Gupta V. G., Park J. O., Żotkiewicz M., Rokutanda N., Cohen G., Oh D.-Y. - Oncol. Res. Treat. - 2023 : bd. 46, suppl. 5, s. 127-128
  64. Platelet RNA enables accurate detection of ovarian cancer: an intercontinental, biomarker identification study - Gao Yue, Liu Chun-Jie, Li Hua-Yi, Xiong Xiao-Ming, Li Gui-Ling, In't Veld Sjors G.J.G., Cai Guang-Yao, Xie Gui-Yan, Zeng Shao-Qing, Wu Yuan, Chi Jian-Hua, Liu Jia-Hao, Zhang Qiong, Jiao Xiao-Fei, Shi Lin-Li, Lu Wan-Rong, Lv Wei-Guo, Yang Xing-Sheng, Piek Jurgen M.J., de Kroon Cornelis D., Lok C.A.R., SUPERNAT ANNA, ŁAPIŃSKA-SZUMCZYK SYLWIA, ŁOJKOWSKA ANNA, ŻACZEK ANNA J., JASSEM JACEK, Tannous Bakhos A., Sol Nik, Post Edward, Best Myron G., Kong Bei-Hua, Xie Xing, Ma Ding, Wurdinger Thomas, Guo An-Yuan, Gao Qing-Lei - Protein Cell - 2023 : vol. 14, nr 6, s. 433-447, bibliogr. [47] poz., streszcz. ang.
  65. Stereotactic management of arrhythmia - radiosurgery in treatment of ventricular tachycardia (SMART-VT) - Miszczyk Marcin, Sajdok Mateusz, Bednarek Jacek, Latusek Tomasz, Wojakowski Wojciech, TOMASIK BARTŁOMIEJ, Wita Krystian, Jadczyk Tomasz, Kurzelowski Radosław, Drzewiecka Anna, Cybulska Magdalena, Gardas Rafał, Jarosiński Grzegorz, Dolla Łukasz, Grządziel Aleksandra, Zub Kamil, Bekman Adam, Kaminiów Konrad, Kozub Anna, Gołba Krzysztof S., Blamek Sławomir - Radiother. Oncol. - 2023 : vol. 188, art ID. 109857, s. 1-7, bibliogr. 33 poz., streszcz. ang.
  66. PERSPECTIVEs on supervised exercise programs in people with metastatic breast cancer - a qualitative study in four European countries - Depenbusch Johanna, Sweegers Maike G., Aaronson Neil K., Wengström Yvonne, Backman Malin, Arraras Juan I., Schranz Melanie, Büchler Britta, LACHOWICZ MILENA, May Anne M., Steindorf Karen, Stuiver Martijn M. - Support. Care Cancer - 2023 : vol. 31, nr 5, art. ID 281, s. 1-11, bibliogr. 44 poz., streszcz. ang.
  67. Perspectives of patients with metastatic breast cancer on physical exercise programs: results from a survey in five European countries - Sweegers Maike G., Depenbusch Johanna, Kampshoff Caroline S., Aaronson Neil K., Hiensch Anouk, Wengström Yvonne, Backman Malin, Gunasekara Nadira, Clauss Dorothea, Pelaez Mireia, LACHOWICZ MILENA, May Anne M., Steindorf Karen, Stuiver Martijn M. - Support. Care Cancer - 2023 : vol. 31, nr 12, art. ID 694, s. 1-13, bibliogr. 41 poz., streszcz. ang.
  68. Current and future applications of liquid biopsy in non-small-cell lung cancer - a narrative review - TOMASIK BARTŁOMIEJ, SKRZYPSKI MARCIN, BIEŃKOWSKI MICHAŁ, DZIADZIUSZKO RAFAŁ, JASSEM JACEK - Transl. Lung Cancer Res. - 2023 : vol. 12, nr 3, s. 594-614, bibliogr. 184 poz., streszcz., ang.
  69. Patient and public involvement in research: reflections and experiences of doctoral cancer nurse researchers in Europe - Tanay M.A., Díez de los Ríos de la Serna C., Boland V., Lopes A.M.D.S., Dornan M., Wingfield K., Yildiz G., Chircop D., SUCHODOLSKA GRAŻYNA, Kurt B., Colomer-Lahiguera S. - Ann. Oncol. - 2022 : vol. 33, suppl. 7, s. S1364
  70. Mobile applications for early breast cancer chemotherapy-related symptoms reporting and management: a scoping review - SUCHODOLSKA GRAŻYNA, SENKUS ELŻBIETA - Cancer Treat. Rev. - 2022 : vol. 105, art. ID 102364, s. 1-9, bibliogr. 38 poz., streszcz. ang.
  71. Profound neutropenia related to consolidation durvalumab treatment following concurrent radiochemotherapy in a patient with stage III nonsmall-cell lung cancer - BANDURA ARTUR, KURLAPSKI MICHAŁ, KAMIŃSKA MAŁGORZATA, DZIADZIUSZKO RAFAŁ, JASSEM JACEK - Pol. Arch. Med. Wewn. - 2022 : vol. 132, nr 2, art. ID 16161, s. 1-2, bibliogr. 5 poz.
  72. Hypofractionated radiotherapy for renal cell carcinoma with inferior vena cava tumour thrombus - Bełdzińska Karolina, GĄDEK KONRAD, RUTKOWSKI JACEK - Współcz. Onkol. - 2022 : vol. 26, nr 4, s. 310-313, bibliogr. 25 poz.
  73. Adding a platinum agent to neoadjuvant chemotherapy for triple-negative breast cancer: the die has not been cast - TOMASIK BARTŁOMIEJ, BIEŃKOWSKI MICHAŁ, JASSEM JACEK - Ann. Oncol. - 2022 : vol. 33, nr 6, s. 658-659, bibliogr. 8 poz.
  74. Datopotamab deruxtecan (Dato-DXd) + durvalumab (D) as first-line (1L) treatment for unresectable locally advanced/metastatic triple-negative breast cancer (a/mTNBC): Initial results from BEGONIA, a phase Ib/II study - Schmid P., Jung K. H., Wysocki P. J., JASSEM JACEK, Ma C. X., Fernandes R., Huisden R., Stewart R., Vukovic P., Tablante Nunes A., Nowecki Z. - Ann. Oncol. - 2022 : vol. 33, suppl. 3, s. S199, abs. 166MO
  75. Current and future diagnostic and treatment strategies for patients with invasive lobular breast cancer - Van Baelen K., Geukens T., Maetens M., Tjan-Heijnen V., Lord C. J., Linn S., Bidard F.-C., Richard F., Yang W. W., Steele R. E., Pettitt S. J., Van Ongeval C., De Schepper M., Isnaldi E., Nevelsteen I., Smeets A., Punie K., Voorwerk L., Wildiers H., Floris G., Vincent-Salomon A., Derksen P. W. B., Neven P., SENKUS ELŻBIETA, Sawyer E., Kok M., Desmedt C. - Ann. Oncol. - 2022 : vol. 33, nr 8, s. 769-785, bibliogr. 210 poz., streszcz. ang.
  76. Adjuvant pertuzumab and trastuzumab in patients with early HER-2 positive breast cancer in APHINITY: 8,4 years' follow-up - Loibl S., JASSEM JACEK, Sonnenblick A., Parlier D., Winer E., Bergh J., Gelber R. D., Restuccia E., Im Y.-H., Huang C., Dalenc F., Calvo I., Procter M., Caballero C., Clark E., Gomez Moreno H. L., Bliss J., Viale G., Bines J., Piccart M. - Ann. Oncol. - 2023 : vol. 33, nr 9, s. 986-987
  77. ESMO expert consensus statements on the management of EGFR mutant non-small-cell lung cancer - Passaro A., Leighl N., Blackhall F., Popat S., Kerr K., Ahn M. J., Arcila M. E., Arrieta O., Planchard D., de Marinis F., Dingemans A. M., DZIADZIUSZKO RAFAŁ, Faivre-Finn C., Feldman J., Felip E., Curigliano G., Herbst R., Jänne P. A., John T., Mitsudomi T., Mok T., Normanno N., Paz-Ares L., Ramalingam S., Sequist L., Vansteenkiste J., Wistuba I. I., Wolf J., Wu Y. L., Yang S. R., Yang J. C. H., Yatabe Y., Pentheroudakis G., Peters S. - Ann. Oncol. - 2022 : vol. 33, nr 5, s. 466-487, bibliogr. 177 poz., streszcz. ang.
  78. ESO-ESMO fifth international consensus guidelines for breast cancer in young women (BCY5) - Paluch-Shimon S., Cardoso F., Partridge A. H., Abulkhair O., Azim H. A., Bianchi-Micheli G., Cardoso M. J., Curigliano G., Gelmon K. A., Gentilini O., Harbeck N., Kaufman B., Kim S. B., Liu Q., Merschdorf J., Poortmans P., Pruneri G., SENKUS ELŻBIETA, Sirohi B., Spanic T., Sulosaari V., Peccatori F., Pagani O. - Ann. Oncol. - 2022 : vol. 33, nr 11, s. 1097-1118, bibliogr. 166 poz., streszcz. ang.
  79. Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer - Geyer, Jr. C. E., Garber J. E., Gelber R. D., Yothers G., Taboada M., Ross L., Rastogi P., Cui K., Arahmani A., Aktan G., Armstrong A. C., Arnedos M., Balmana J., Bergh J., Bliss J., Delaloge S., Domchek S. M., Eisen A., Elsafy F., Fein L. E., Fielding A., Ford J. M., Friedman S., Gelmon K. A., Gianni L., Gnant M., Hollingsworth S. J., Im S.-A., Jager A., Jóhannsson Ó. P., Lakhani S. R., Janni W., Linderholm B., Liu T.-W., Loman N., Korde L., Loibl S., Lucas P. C., Marmé F., Martinez de Duenas E., McConnell R., Phillips K.-A., Piccart M., Rossi G., Schmutzler R., SENKUS ELŻBIETA, Shao Z., Sharma P., Singer C. F., Španić T., Stickeler E., Toi M., Traina T. A., Viale G., Zoppoli G., Park Y. H., Yerushalmi R., Yang H., Pang D., Jung K. H., Mailliez A., Fan Z., Tennevet I., Zhang J., Nagy T., Sonke G. S., Sun Q., Parton M., Colleoni M. A., Schmidt M., Brufsky A. M., Razaq W., Kaufman B., Cameron D., Campbell C., Tutt A. N. J. - Ann. Oncol. - 2022 : vol. 33, nr 12, s. 1250-1268, bibliogr. 31 poz., streszcz. ang.
  80. Assessment of cervical vascularization density in patients with locally advanced squamous cell cervical carcinoma evaluated in colour Doppler and power Doppler functions - Tomalczyk Adam, TOMASIK BARTŁOMIEJ, Fijuth Jacek, Moszyńska-Zielińska Małgorzata, Gottwald Leszek - Arch. Gynecol. Obstet. - 2022 : vol. 305, nr 4, s. 955-961, bibliogr. 24 poz., streszcz. ang.
  81. Ultra-hypofractionated stereotactic body radiotherapy for localized prostate cancer: clinical outcomes, patterns of recurrence, feasibility of definitive salvage treatment, and competing oncological risk - Miszczyk Marcin, Szołtysik Monika, Hasterok Maja, Goldner Gregor, Rajwa Paweł, Namysł-Kaletka Agnieszka, Napieralska Aleksandra, Kraszkiewicz Małgorzata, Stąpór-Fudzińska Małgorzata, TOMASIK BARTŁOMIEJ, Woźniak Grzegorz, Głowacki Grzegorz, Kaminiów Konrad, Moll Matthias, Magrowski Łukasz, Majewski Wojciech - Biomedicines - 2022 : vol. 10, nr 10, art. ID 2446, s. 1-12, bibliogr. 36 poz., streszcz. ang.
  82. Current challenges and unmet needs in treating patients with human epidermal growth factor receptor 2-positive advanced breast cancer - Aapro Matti, Cardoso Fatima, Curigliano Giuseppe, Eniu Alexandru, Gligorov Joseph, Harbeck Nadia, Mueller Andreas, Pagani Olivia, Paluch-Shimon Shani, SENKUS ELŻBIETA, Thürlimann Beat, Zaman Khalil - Breast - 2022 : vol. 66, s. 145-156, bibliogr. 107 poz., streszcz. ang.
  83. Detection and localization of early- and late-stage cancers using platelet RNA - In 't Veld Sjors G. J. G., Arkani Mohammad, Post Edward, Antunes-Ferreira Mafalda, DAmbrosi Silvia, Vessies Daan C. L., Vermunt Lisa, Vancura Adrienne, Muller Mirte, Niemeijer Anna-Larissa N., Tannous Jihane, Meijer Laura L., Le Large Tessa Y. S., Mantini Giulia, Wondergem Niels E., Heinhuis Kimberley M., van Wilpe Sandra, Smits A. Josien, Drees Esther E. E., Roos Eva, Leurs Cyra E., Tjon Kon Fat Lee-Ann, van der Lelij Ewoud J., Dwarshuis Govert, Kamphuis Maarten J., Visser Lisanne E., Harting Romee, Gregory Annemijn, Schweiger Markus W., Wedekind Laurine E., Ramaker Jip, Zwaan Kenn, Verschueren Heleen, Bahce Idris, de Langen Adrianus J., Smit Egbert F., van den Heuvel Michel M., Hartemink Koen J., Kuijpers Marijke J. E., oude Egbrink Mirjam G. A., Griffioen Arjan W., Rossel Rafael, Hiltermann T. Jeroen N., Lee-Lewandrowski Elizabeth, Lewandrowski Kent B., De Witt Hamer Philip C., Kouwenhoven Mathilde, Reijneveld Jaap C., Leenders William P. J., Hoeben Ann, Verdonck-de Leeuw Irma M., Leemans C. René, Baatenburg de Jong Robert J., Terhaard Chris H. J., Takes Robert P., Langendijk Johannes A., de Jager Saskia C., Kraaijeveld Adriaan O., Pasterkamp Gerard, Smits Minke, Schalken Jack A., ŁAPIŃSKA-SZUMCZYK SYLWIA, ŁOJKOWSKA ANNA, ŻACZEK ANNA J., Lokhorst Henk, van de Donk Niels W. C. J., Nijhof Inger, Prins Henk-Jan, Zijlstra Josée M., Idema Sander, Baayen Johannes C., Teunissen Charlotte E., Killestein Joep, Besselink Marc G., Brammen Lindsay, Bachleitner-Hofmann Thomas, Mateen Farrah, Plukker John T. M., Heger Michal, de Mast Quirijn, Lisman Ton, Pegtel D. Michiel, Bogaard Harm-Jan, JASSEM JACEK, SUPERNAT ANNA, Mehra Niven, Gerritsen Winald, de Kroon Cornelis D., Lok Christianne A. R., Piek Jurgen M. J., Steeghs Neeltje, van Houdt Winan J., Brakenhoff Ruud H., Sonke Gabe S., Verheul Henk M., Giovannetti Elisa, Kazemier Geert, Sabrkhany Siamack, Schuuring Ed, Sistermans Erik A., Wolthuis Rob, Meijers-Heijboer Hanne, Dorsman Josephine, Oudejans Cees, Ylstra Bauke, Westerman Bart A., van den Broek Daan, Koppers-Lalic Danijela, Wesseling Pieter, Nilsson R. Jonas A., Vandertop W. Peter, Noske David P., Tannous Bakhos A., Sol Nik, Best Myron G., Wurdinger Thomas - Cancer Cell - 2022 : vol. 40, nr 9, s. 999-1009.e6, bibliogr. [44] poz., streszcz. ang.
  84. PARP inhibitors for metastatic castration-resistant prostate cancer: biological rationale and current evidence - BIEŃKOWSKI MICHAŁ, TOMASIK BARTŁOMIEJ, Braun Marcin, JASSEM JACEK - Cancer Treat. Rev. - 2022 : vol. 104, art. ID 102359, s. 1-12, bibliogr. 151 poz., streszcz. ang.
  85. New genetic technologies in diagnosis and treatment of cancer of unknown primary - Krawczyk Paweł, JASSEM JACEK, Wojas-Krawczyk Kamila, Krzakowski Maciej, DZIADZIUSZKO RAFAŁ, Olszewski Włodzimierz - Cancers - 2022 : vol. 14, nr 14, art. ID 3429, s. 1-13, bibliogr. 76 poz., streszcz. ang.
  86. Management strategies for hyperglycemia associated with the α-selective PI3K inhibitor alpelisib for the treatment of breast cancer - Tankova Tsvetalina, SENKUS ELŻBIETA, Beloyartseva Maria, Borštnar Simona, Catrinoiu Doina, Frolova Mona, Hegmane Alinta, Janež Andrej, Krnić Mladen, Lengyel Zoltan, Marcou Yiola, Mazilu Laura, Mrinakova Bela, Percik Ruth, Petrakova Katarina, Rubovszky Gábor, Tokar Margarita, Vrdoljak Eduard - Cancers - 2022 : vol. 14, nr 7, art. ID 1598, s. 1-14, bibliogr. 56 poz., streszcz. ang.
  87. The influence of radiotherapy on the function of the left and right ventricles in relation to the radiation dose administered to the left anterior descending coronary artery - from a cardiologists point of view - NABIAŁEK-TROJANOWSKA IZABELA, Sinacki Marcin, JANKOWSKA HANNA, LEWICKA-POTOCKA ZUZANNA, DZIADZIUSZKO RAFAŁ, LEWICKA EWA - Cancers - 2022 : vol. 14, nr 10, art. ID 2420, s. 1-13, bibliogr. 33 poz., streszcz. ang.
  88. Radiotherapy for leptomeningeal carcinomatosis in breast cancer patients: a narrative review - PAWŁOWSKA EWA, Romanowska Anna, JASSEM JACEK - Cancers - 2022 : vol. 14, nr 16, art. ID 3899, s. 1-18, bibliogr. 71 poz., streszcz. ang.
  89. Circulating cell-free DNA as a prognostic biomarker in patients with advanced ALK+ non-small cell lung cancer in the global phase III ALEX trial - DZIADZIUSZKO RAFAŁ, Peters Solange, Mok Tony, Camidge D. Ross, Gadgeel Shirish M., Ou Sai-Hong Ignatius, KONOPA KRZYSZTOF, Noé Johannes, Nowicka Malgorzata, Bordogna Walter, Morcos Peter N., Smoljanovic Vlatka, Shaw Alice T. - Clin. Cancer Res. - 2022 : vol. 28, nr 9, s. 1800-1808, bibliogr. 29 poz., streszcz. ang.
  90. Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors - Demetri George D., de Braud Filippo, Drilon Alexander, Siena Salvatore, Patel Manish R., Cho Byoung Chul, Liu Stephen V., Ahn Myung-Ju, Chiu Chao-Hua, Lin Jessica J., Goto Koichi, Lee Jeeyun, Bazhenova Lyudmila, John Thomas, Fakih Marwan, Chawla Sant P., DZIADZIUSZKO RAFAŁ, Seto Takashi, Heinzmann Sebastian, Pitcher Bethany, Chen David, Wilson Timothy R., Rolfo Christian - Clin. Cancer Res. - 2022 : vol. 28, nr 7, s. 1302-1312, bibliogr. 21 poz., streszcz. ang.
  91. Role of postoperative radiotherapy in the management for resected NSCLC -decision criteria in clinical routine pre- and post-lungART - Süveg Krisztian, Le Pechoux Cecile, Faivre-Finn Corinne, Putora Paul M., De Ruysscher Dirk, Widder Joachim, Van Houtte Paul, Troost Esther G.C., Slotman Ben J., Ramella Sara, Pöttgen Christoph, Peeters Stephanie T.H., Nestle Ursula, McDonald Fiona, DZIADZIUSZKO RAFAŁ, Belderbos José, Ricardi Umberto, Manapov Farkhad, Lievens Yolande, Geets Xavier, Dieckmann Karin, Guckenberger Matthias, Andratschke Nicolaus, Glatzer Markus - Clin. Lung Cancer - 2022 : vol. 22, nr 6, s. 579-586, bibliogr. 51 poz., streszcz. ang.
  92. Impact of tobacco smoking on outcomes of radiotherapy: a narrative review - PERDYAN ADRIAN, JASSEM JACEK - Curr. Oncol. - 2022 : vol. 29, nr 4, s. 2284-2300, bibliogr. 69 poz., streszcz. ang.
  93. Tepotinib for advanced non-small-cell lung cancer with MET exon 14 skipping mutations - BŁASZKOWSKA MAGDALENA, SPECHT-SZWOCH ZOFIA, DZIADZIUSZKO RAFAŁ - ESMO Open - 2022 : vol. 7, nr 2, art. ID 100449, s. 1-2, bibliogr. 9 poz.
  94. Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinibpretreated ALK-positive non-small-cell lung cancer - Wolf J., Helland Å, Oh I.-J., Migliorino M. R., DZIADZIUSZKO RAFAŁ, WRONA ANNA, de Castro J., Mazieres J., Griesinger F., Chlistalla M., Cardona A., Ruf T., Trunzer K., Smoljanovic V., Novello S. - ESMO Open - 2022 : vol. 7, nr 1, art. ID 100333, s. 1-8, bibliogr. 29 poz., streszcz. ang.
  95. Clinical experience and management of adverse events in patients with advanced ALK-positive non-small-cell lung cancer receiving alectinib - DZIADZIUSZKO RAFAŁ, Peters S., Ruf T., Cardona A., Guerini E., Kurtsikidze N., Smoljanovic V., Planchard D. - ESMO Open - 2022 : vol. 7, nr 6, art. ID 100612, s. 1-10, bibliogr. 40 poz., streszcz. ang.
  96. The need for a comprehensive and integrated approach to lung cancer policy in Europe - Racovita Monica, Wheeler Eleanor, Wait Suzanne, Albreht Tit, Baird Anne-Marie, JASSEM JACEK, McNamara Aoife, Novello Silvia, Radu-Loghin Cornel, Van Meerbeeck Jan P. - Eur. J. Cancer - 2022 : vol. 175, s. 54-59, bibliogr. 30 poz., streszcz. ang.
  97. WHO CNS5 2021 classification of gliomas: a practical review and road signs for diagnosing pathologists and proper patho-clinical and neuro-oncological cooperation - Sejda Aleksandra, Grajkowska Wiesława, Trubicka Joanna, SZUTOWICZ EWA, Wojdacz Tomasz Kazimierz, Kloc Wojciech, IŻYCKA-ŚWIESZEWSKA EWA - Folia Neuropathol. - 2022 : vol. 60, nr 2, s. 137-152, bibliogr. 87 poz., sterszcz. ang.
  98. Case report: TFE3 positive Xp11.2 translocation renal cell carcinoma (TRCC) - a case study and review of the literature - Miroński Ignacy, Zaucha Jan Mateusz, KOWALSKI JACEK, ZAUCHA RENATA - Front. Oncol. - 2022 : vol. 11, art. ID 826325, s. 1-7, bibliogr. 33 poz., streszcz. ang.
  99. Replication stress: a review of novel targets to enhance radiosensitivity - from bench to clinic - Zhang Yuewen, Wu Lei, Wang Zhao, Wang Jinpeng, Roychoudhury Shrabasti, TOMASIK BARTŁOMIEJ, Wu Gang, Wang Geng, Rao Xinrui, Zhou Rui - Front. Oncol. - 2022 : vol. 12, art. ID 838637, s. 1- 23, bibliogr. 227 poz., streszcz. ang.
  100. Towards better pharmaceutical provision in Europe - who decides the future? - Horgan Denis, Spanic Tanja, Apostolidis Kathi, Curigliano Giuseppe, Chorostowska-Wynimko Joanna, Dauben Hans-Peter, Lal Jonathan A., DZIADZIUSZKO RAFAŁ, Mayer-Nicolai Christine, Kozaric Marta, Jönsson Bengt, Gutierrez-Ibarluzea Inaki, Fandel Marie-Helene, Lopert Ruth - Healthcare (Basel) - 2022 : vol. 10, nr 8, art. ID 1594, s. 1-17, bibliogr. 75 poz., streszcz. ang.
  101. The role of 3D printing in planning complex medical procedures and training of medical professionals - cross-sectional multispecialty review - MEYER-SZARY JAROSŁAW, SOUZA LUIS MARLON, Mikulski Szymon, PATEL AGASTYA, Schulz Finn, TRETIAKOW DMITRY, FERCHO JUSTYNA, JAGUSZEWSKA KINGA, FRANKIEWICZ MIKOŁAJ, PAWŁOWSKA EWA, Targoński Radosław, Szarpak Łukasz, Dądela Katarzyna, SABINIEWICZ ROBERT, KWIATKOWSKA JOANNA - Int. J. Environ. Res. Public Health - 2022 : vol. 19, nr 6, art. ID 3331, s. 1-38, bibliogr. 188 poz., streszcz. ang.
  102. Complementary and alternative therapies in oncology - Dawczak-Dębicka Agnieszka, Kufel-Grabowska Joanna, Bartoszkiewicz Mikołaj, PERDYAN ADRIAN, JASSEM JACEK - Int. J. Environ. Res. Public Health - 2022 : vol. 19, nr 9, art. ID 5071, s. 1-15, bibliogr. 108 poz., streszcz. ang.
  103. Being a young radiation oncologist in Poland : results of a multi-institutional survey - PAWŁOWSKA EWA, Tomasik Bartlomiej, Spałek Mateusz, Chyrek Artur J., Napieralska Aleksandra - J. Cancer Educ. - 2022 : vol. 37, nr 6, s. 1614-1620, bibliogr. 17 poz., streszcz. ang.
  104. ESO-ESSO-ESTRO multidisciplinary course in oncology for medical students: 4 years of experience (2016-2019) - Pavlidis Nicholas, Madry Radoslaw, Peeters Marc, Sandrucci Sergio, Markowska Janina, Peccatori Fedro, Costa Alberto, Eriksen Jesper Grau, Ricardi Umberto, Poetter Richard, Schrijvers Drisk, Vermorken Jan B., i in., SENKUS-KONEFKA ELŻBIETA - J. Cancer Educ. - 2022 : vol. 37, nr 4, s. 1239-1244, bibliogr. 28 poz., streszcz. ang.
  105. Cancer care for Ukrainian refugees: strategic impact assessments in the early days of the conflict - Van Hemelrijck M., Fox L., Beyer K., Fedaraviciute E., George G., Hadi H., Haire A., Handford J., Mera A., Monroy-Iglesias M. J., Moss C. L., Perdek N., Russell B., Santaolalla A., Sztankay M., Wylie H., JASSEM JACEK, Zubaryev M., Anderson B. O., Ortiz R., Ilbawi A., Camacho R., Ferreira-Borges C., Roitberg F., Dvaladze A. E., Lasierra Losada M., Alves da Costa F., Aggarwal A., Lawler M., Kopetskiy S., Sullivan R. - J. Cancer Policy - 2022 : vol. 34, art. ID 100370, s. 1-8, bibliogr. 41 poz., streszcz. ang.
  106. Management of pheochromocytomas and paragangliomas: a case-based review of clinical aspects and perspectives - Sobocki Bartosz Kamil, PERDYAN ADRIAN, Szot Olga, RUTKOWSKI JACEK - J. Clin. Med. - 2022 : vol. 11, nr 9, art. ID 2591, s. 1-18, bibliogr. 104 poz., streszcz. ang.
  107. EPIK-B5: A phase III, randomized study of alpelisib (ALP) plus fulvestrant (FUL) in patients with hormone receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-), PIK3CA-mutated advanced breast cancer (ABC) progressing on/after an aromatase inhibitor (AI) with a cyclin-dependent kinase 4/6 inhibitor (CDK4/6i) - De Laurentiis Michelino, Costa Luis, Gligorov Joseph, Knop Ann, SENKUS-KONEFKA ELŻBIETA, García-Sáenz José A., Schmid Peter, Heniquez Aurelia, Serra Paolo, Reising Albert, Kuemmel Sherko - J. Clin. Oncol. - 2022 : vol. 40, nr 16, suppl., abs. TPS1109
  108. First-line (1L) nivolumab (NIVO) + ipilimumab (IPI) + 2 cycles of chemotherapy (chemo) versus chemo alone (4 cycles) in patients (pts) with metastatic non-smal cel lung cancer (NSCLC): 3-year update from CheckMate 9LA - Paz-Ares Luiz G., Ciuleanu Tudor-Eliade, Cobo-Dols Manuel, Bennouna Jaafar, Cheng Ying, Mizutani Hideaki, Lingua Alejo, Reyes Felipe, Reinmuth Niels, Janoski De Menezes Juliana, JASSEM JACEK, Protsenko Svetlana, Feeney Kynan, de la Mora Jimenez Emmanuel, Lu Shun, John Tom, Carbone David Paul, Zhang Xiaoqing, Hu Nan, Reck Martin - J. Clin. Oncol. - 2022 : vol. 40, nr 17, suppl., abs. LBA9026
  109. miRNA signatures of prognostic significance in single hormone receptor-positive breast cancer - SENKUS-KONEFKA ELŻBIETA, POPĘDA MARTA, KUNC MICHAŁ, BIEŃKOWSKI MICHAŁ, Braun Marcin, Lacko Aleksandra, Radecka Barbara, Pikiel Joanna, Litwiniuk Maria, Pogoda Katarzyna, IŻYCKA-ŚWIESZEWSKA EWA, ŻACZEK ANNA JOANNA, BIERNAT WOJCIECH - J. Clin. Oncol. - 2022 : vol. 40, nr 16, suppl., abs. e12544
  110. Post hoc analysis of lorlatinib intracranial efficacy and safety in patients with ALK-positive advanced non-small-cell lung cancer from the phase III CROWN Study - Solomon Benjamin J., Bauer Todd M., Ou Sai-Hong Ignatius, Liu Geoffrey, Hayashi Hidetoshi, Bearz Alessandra, Penkov Konstantin, Wu Yi-Long, Arrieta Oscar, JASSEM JACEK, Calella Anna M., Peltz Gerson, Polli Anna, Thurm Holger, Mok Tony - J. Clin. Oncol. - 2022 : vol. 40, nr 31, s. 3593-3602, bibliogr. 27 poz., streszcz. ang.
  111. Phase 3 trial of lorlatinib in treatment-naive patients (Pts) withALK-positive advanced non-small cell lung cancer (NSCLC): comprehensive plasma and tumor genomic analyses - Bearz Alessandra, Martini Jean-François, JASSEM JACEK, Kim Sang-We, Chang Gee-Chen, Shaw Alice Tsang, Shepard Deborah, Dall'O' Elisa, Polli Anna, Thurm Holger C., Zalcman Gerard, Campelo Rosario Garcia, Penkov Konstantin, Hayashi Hidetoshi, Solomon Benjamin J. - J. Clin. Oncol. - 2022 : vol. 40, nr 16, suppl., abs. TPS9070
  112. Analysis of efficacy and safety of vismodegib therapy in patients with advanced basal cell carcinoma - real world multicenter cohort study - Słowińska M., Dudzisz-Śledź M., Sobczuk P., Łasińska I., Pietruszka A., Cybulska-Stopa B., KOWALCZYK ANNA, Świtaj T., Czarnecka I., Koseła-Paterczyk H., Rogala P., Paluchowska E., Składowski K., Mackiewicz J., Rutkowski P., Owczarek W. - J. Eur. Acad. Dermatol. Venereol. - 2022 : vol. 36, nr 8, s. 1219-1228, bibliogr. 31 poz., streszcz. ang.
  113. Loss of STING expression is prognostic in non-small cell lung cancer - Lohinai Zoltan, Dora David, Caldwell jr Charles, Rivard Christopher J., Suda Kenichi, Yu Hui, Rivalland Gareth, Ellison Kim, Rozeboom Leslie, DZIADZIUSZKO RAFAŁ, Mitchell Paul, John Thomas, Millan Inigo S., Ren Shengxiang, Hirsch Fred R. - J. Surg. Oncol. - 2022 : vol. 125, nr 6, s. 1042-1052, bibliogr. 40 poz., streszcz. ang.
  114. Complex EGFR mutations in non-small cell lung cancer: a distinct entity? - BIEŃKOWSKI MICHAŁ, DZIADZIUSZKO RAFAŁ, JASSEM JACEK - J. Thorac. Dis. - 2022 : vol. 14, nr 8, s. 2738-2741, bibliogr. 25 poz.
  115. Brief report: exploratory analysis of maintenance therapy in patients with extensive-stage SCLC treated first line with atezolizumab plus carboplatin and etoposide - Reck Martin, Mok Tony S. K., Mansfield Aaron, De Boer Richard, Losonczy Gyorgy, Sugawara Shunichi, DZIADZIUSZKO RAFAŁ, Krzakowski Maciej, Smolin Alexey, Hochmair Maximilian, Garassino Marina Chiara, de Castro Junior Gilberto, Bischoff Helge, Lam Sivuonthanh, Cardona Andres, Morris Stefanie, Liu Stephen V. - J. Thorac. Oncol. - 2022 : vol. 17, nr 9, s. 1122-1129, bibliogr. 19 poz., streszcz. ang.
  116. STK11 and KEAP1 mutations in lung adenocarcinoma: solving the puzzle continues - DZIADZIUSZKO RAFAŁ - J. Thorac. Oncol. - 2022 : vol. 17, nr 3, s. 351-352, bibliogr. 5 poz.
  117. Nivolumab versus sorafenib in advanced hepatocellular carcinoma (CheckMate 459): a randomised, multicentre, open-label, phase 3 trial - Yau Thomas, Park Joong-Won, Finn Richard S., Cheng Ann-Lii, Mathurin Philippe, Edeline Julien, Kudo Masatoshi, Harding James J., Merle Philippe, Rosmorduc Olivier, Wyrwicz Lucjan, Schott Eckart, Pin Choo Su, Kelley Robin Kate, Sieghart Wolfgang, Assenat Eric, ZAUCHA RENATA, Furuse Junji, Abou-Alfa Ghassan K., El-Khoueiry Anthony B., Melero Ignacio, Begic Damir, Chen Gong, Neely Jaclyn, Wisniewski Tami, Tschaika Marina, Sangro Bruno - Lancet Oncol. - 2022 : vol. 23, nr 1, s. 77-90, bibliogr. 35 poz., streszcz. ang.
  118. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castrationresistant prostate cancer : a randomised, double-blind, phase 2 trial - Saad Fred, Thiery-Vuillemin Antoine, Wiechno Pawel, Alekseev Boris, Sala Nuria, Jones Robert, Kocak Ivo, Chiuri Vincenzo Emanuele, JASSEM JACEK, Fléchon Aude, Redfern Charles, Kang Jinyuv, Burgents Joseph, Gresty Christopher, Degboe Arnold, Clarke Noel W - Lancet Oncol. - 2022 : vol. 23, nr 10, s. 1297-1307, bibliogr. 30 poz., streszcz. ang.
  119. Continuous enzalutamide after progression of metastatic castration-resistant prostate cancer treated with docetaxel (PRESIDE) : an international, randomised, phase 3b study - Merseburger Axel S., Attard Gerhardt, Åström Lennart, Matveev Vsevolod B., Bracarda Sergio, Esen Adil, Feyerabend Susan, SENKUS ELŻBIETA, López-Brea Piqueras Marta, Boysen Gunther, Gourgiot Georgi, Martins Karla, Chowdhury Simon - Lancet Oncol. - 2022 : vol. 23, nr 11, s. 1398-1408, bibliogr. 28 poz., streszcz. ang.
  120. European Society for Radiotherapy and Oncology Advisory Committee in Radiation Oncology Practice consensus recommendations on patient selection and dose and fractionation for external beam radiotherapy in early breast cancer - Meattini Icro, Becherini Carlotta, Boersma Liesbeth, Kaidar-Person Orit, Gustavo Nader Marta, Montero Angel, Vrou Offersen Birgitte, Aznar Marianne C., Belka Claus, Brunt Murray Adrian, Dicuonzo Samantha, Franco Pierfrancesco, Krause Mechthild, Mackenzie Mairead, Marinko Tanja, Marrazzo Livia, Ratosa Ivica, Scholten Astrid, SENKUS ELŻBIETA, Stobart Hilary, Poortmans Philip, Coles Charlotte - Lancet Oncol. - 2022 : vol. 23, nr 1, s. e21-e31, bibliogr. 68 poz., streszcz. ang.
  121. Retrospective analysis of the effectiveness of volumetric modulated arc therapy half-body irradiation in palliation of pain in patients with multiple bone metastases - Kluska Adam, TOMASIK BARTŁOMIEJ, Osadnik Arkadiusz, Tracz Natalia, Trąbska-Kluch Berenika, Matysiak Paweł, Łuniewska-Bury Jolanta, Fijuth Jacek, Gottwald Leszek - Mol. Clin. Oncol. - 2022 : vol. 17, nr 5, art. ID 153, s. 1-6, bibliogr. 18 poz., streszcz. ang.
  122. Pre- and post-treatment blood-based genomic landscape of patients with ROS1 or NTRK fusion-positive solid tumours treated with entrectinib - DZIADZIUSZKO RAFAŁ, Hung Tiffany, Wang Kun, Choeurng Voleak, Drilon Alexander, Doebele Robert C., Barlesi Fabrice, Wu Charlie, Dennis Lucas, Skoletsky Joel, Woodhouse Ryan, Li Meijuan, Chang Ching-Wei, Simmons Brian, Riehl Todd, Wilson Timothy R. - Mol. Oncol. - 2022 : vol.16, nr 10, s. 2000-2014, bibliogr. 43 poz., streszcz. ang.
  123. Atezolizumab versus chemotherapy in advanced or metastatic NSCLC with high blood-based tumor mutational burden: primary analysis of BFAST cohort C randomized phase 3 trial - Peters Solange, DZIADZIUSZKO RAFAŁ, Morabito Alessandro, Felip Enriqueta, Gadgeel Shirish M., Cheema Parneet, Cobo Manuel, Andric Zoran, Barrios Carlos H., Yamaguchi Masafumi, Dansin Eric, Danchaivijitr Pongwut, Johnson Melissa, Novello Silvia, Mathisen Michael S., Shagan Sarah M., Schleifman Erica, Wang Jin, Yan Mark, Mocci Simonetta, Voong David, Fabrizio David A., Shames David S., Riehl Todd, Gandara David R., Mok Tony - Nat. Med. - 2022 : vol. 28, nr 9, s. 1831-1839, bibliogr. 45 poz., streszcz. ang.
  124. Thoracic neoplasms - Krzakowski Maciej, JASSEM JACEK, Antczak Adam, Błasińska Katarzyna, Chrostowska-Wynimko Joanna, DZIADZIUSZKO RAFAŁ, Głogowski Maciej, Grodzki Tomasz, Kowalski Dariusz, Krenke Rafał, Langfort Renata, Olszewski Włodzimierz, Orłowski Tadeusz, Śliwiński Paweł, Tysarowski Andrzej, RZYMAN WITOLD, Woźniewski Marek - Oncol. Clin. Pract. - 2022 : vol 18, nr 1, s. 1-39, bibliogr. 164 poz.
  125. High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/ progesterone receptor-positive breast cancer: results of comprehensive re-evaluation of multi-institutional case series - KUNC MICHAŁ, PĘKSA RAFAŁ, Cserni Gabor, IŻYCKA-ŚWIESZEWSKA EWA, Łacko Aleksandra, Radecka Barbara, Braun Marcin, Pikiel Joanna, Litwiniuk Maria, Pogoda Katarzyna, Szwajkosz Anna, BIERNAT WOJCIECH, SENKUS ELŻBIETA - Pathology - 2022 : vol. 54, nr 3, s. 269-278, bibliogr. 31 poz., streszcz. ang.
  126. The clinician's guide to radiotherapy complications - Fendler Wojciech, TOMASIK BARTŁOMIEJ, Atkins Katelyn, Stawiski Konrad, Chałubińska-Fendler Justyna, Kozono David - Pol. Arch. Med. Wewn. - 2022 : vol. 132, nr 1, art. ID 16190, s. 1-11, bibliogr. 100 poz., streszcz. ang.
  127. Conventionally fractionated radiotherapy versus CyberKnife hypofractionated radiotherapy for painful vertebral haemangiomas - a randomized clinical trial - Miszczyk Marcin, Napieralska Aleksandra, Woźniak Grzegorz, Kraszkiewicz Małgorzata, Gola Michał, Kalemba Michał, Głowacki Grzegorz, TOMASIK BARTŁOMIEJ, Kocot-Kępska Magdalena, Miszczyk Leszek - Radiother. Oncol. - 2022 : vol. 176, s. 46-52, bibliogr. 26 poz., streszcz. ang.
  128. Serum miRNA-based signature indicates radiation exposure and dose in humans: - Nowicka Zuzanna, TOMASIK BARTŁOMIEJ, Kozono David, Stawiski Konrad, Johnson Thomas, Haas-Kogan Daphne, Ussowicz Marek, Chowdhury Dipanjan, Fendler Wojciech - Radiother. Oncol. - 2023 : vol. 185, art. ID 109731, s. 1-8, bibliogr. 30 poz., streszcz. ang.
  129. Induction of 2-hydroxycatecholestrogens O-methylation: A missing puzzle piece in diagnostics and treatment of lung cancer - MUSIAŁ CLAUDIA, KNAP NARCYZ, ZAUCHA RENATA, BASTIAN PAULINA, Barone Giampaolo, Lo Bosco Giosuè, Lo-Celso Fabrizio, KONIECZNA LUCYNA, BELKA MARIUSZ, BĄCZEK TOMASZ, Gammazza Antonella Marino, KUBAN-JANKOWSKA ALICJA, Cappello Francesco, Nussberger Stephan, GÓRSKA-PONIKOWSKA MAGDALENA - Redox Biol. - 2022 : vol. 55, art. ID 102395, s. 1-13, bibliogr. 104 poz., streszcz. ang.
  130. Contralateral esophageal sparing technique in definitive radiotherapy for non-small cell lung cancer: dosimetric parameters and normal tissue complication probability modeling - Łazar-Poniatowska Małgorzata, KAMIŃSKA JOANNA, KONOPA KRZYSZTOF, DZIADZIUSZKO RAFAŁ, JASSEM JACEK - Rep. Pract. Oncol. Radiother. - 2022 : vol. 27, nr 6, s. 933-942, bibliogr. 25 poz., streszcz. ang.
  131. Pathway-level mutation analysis in primary high-grade serous ovarian cancer and matched brain metastases - Duchnowska Renata, SUPERNAT ANNA MARIA, PĘKSA RAFAŁ, Łukasiewicz Marta, STOKOWY TOMASZ, Ronen Ron, Dutkowski Janusz, Umińska Monika, IŻYCKA-ŚWIESZEWSKA EWA, KOWALCZYK ANNA, Och Waldemar, Rucińska Monika, Olszewski Wojciech P., Mandat Tomasz, Jarosz Bożena, BIEŃKOWSKI MICHAŁ, BIERNAT WOJCIECH, JASSEM JACEK - Sci. Rep. - 2022 : vol. 12, art. ID 20537, s. 1-9, bibliogr. 53 poz., streszcz. ang.
  132. Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform - Morfouace M., Novello S., Stevovic A., Dooms C., Janžič U., Berghmans T., DZIADZIUSZKO RAFAŁ, Gorlia T., Felip E., Paz-Ares L., Mazieres J., O'Brien M., Bironzo P., Vansteenkiste J., Lacroix L., Dingemans A.C., Golfinopoulos V., Besse B. - Sci. Rep. - 2022 : vol. 12, art. ID 8342, s. 1-11, bibliogr. 15 poz., streszcz. ang.
  133. Lung cancer in Europe: the way forward - Racovita Monica, Wheeler Eleanor, Wait Suzanne, Bancroft Dani, Eastabrook Rowan, Albreht Tit, Baird Anne-Marie, JASSEM JACEK, McNamara Aoife, Novello Silvia, Radu-Loghin Cornel, Van Meerbeeck Jan P. - Tob. Prev. Cessat. - 2022 : vol. 8, art. ID 6, s. 1-2, bibliogr. 13 poz.
  134. Design of a multinational randomized controlled trial to assess the effects of structured and individualized exercise in patients with metastatic breast cancer on fatigue and quality of life: the EFFECT study - Hiensch Anouk E., Monninkhof Evelyn M., Schmidt Martina E., Zopf Eva M., Bolam Kate A., Aaronson Neil K., Belloso Jon, Bloch Wilhelm, Clauss Dorothea, Depenbusch Johanna, LACHOWICZ MILENA, Pelaez Mireia, Rundqvist Helene, SENKUS ELŻBIETA, Stuiver Martijn M., Trevaskis Mark, Urruticoechea Ander, Rosenberger Friederike, van der Wall Elsken, de Wit G. Ardine, Zimmer Philipp, Wengström Yvonne, Steindorf Karen, May Anne M. - Trials - 2022 : vol. 23, art. ID 610, s. 1-14, bibliogr. 50 poz., streszcz. ang.
  135. Establishment of a virtual transborder tumor board for cancer patients in Central and Southeastern Europe. An initiative of the Central European Cooperative Oncology Group (CECOG) - Thallinger Christiane, Berzinec Peter, Bicakcic Emina, Dan Adelina, Fabian Gabriella, Gales Laurentia Nicoletta, Kuhar Cvetka Grasic, Janzic Urska, Kahan Zsusanna, Mencinger Marina, Penthedourakis George, Sgouros Joseph, Simetic Luka, Sirbu Daniela, Vosmik Milan, WRONA ANNA, Zielinski Christoph - Wien. Klin. Wochenschr. - 2022 : vol. 134, nr 19/20, s. 697-704, bibliogr. 12 poz., streszcz. ang.
Aktualizacja strony: 07.02.2023
Helpdesk IT